Anika Therapeutics, Inc. (ANIK) Reports Improved Q4 EPS of $0.21
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.38 -2.44%
Revenue Growth %: +7.0%
Financial Fact:
Basic weighted average common shares outstanding: 14.63M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +7.0%
Financial Fact:
Basic weighted average common shares outstanding: 14.63M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.21, versus $0.10 reported last year. Revenue for the quarter came in at $18.4 million, versus $14.7 million reported last year.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Teamshares raises $225M in preferred equity from T. Rowe Price
- Visa deposits $405M into U.S. litigation escrow, adjusting stock rates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
